Last reviewed · How we verify

NCT07344038

Bioceramic Putty Versus MTA in Pulpotomized Primary Teeth to be Covered With 3D Printed Resin Crowns Versus Stainless Steel Crown

Recruiting now NA Last updated 15 January 2026
What this trial tests

NA trial testing Endo-sequence bioceramic putty pulpotomy in Caries Active in 60 participants. Currently enrolling.

Timeline
20 January 2026
Primary endpoint
15 February 2026
15 April 2027

Quick facts

Lead sponsorAlexandria University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date20 January 2026
Primary completion15 February 2026
Estimated completion15 April 2027
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Alexandria University

Who can join

Adults 5 to 7, any sex, with Caries Active. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

children aged 5 to 7 years with deep carious second primary molars that require vital pulp therapy will be treated using either MTA or bioceramic putty, then will be fully covered using either stainless steel crowns or 3D printed resin crowns.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Alexandria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07344038.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing